The XCell-Center has released results from a follow-up study of 115 spinal cord injury patients treated with autologous bone marrow stem cells. Overall, nearly 6o% improved following treatment.
Dusseldorf, Germany (PRWEB) October 21, 2009 -- The XCell-Center has released results from a follow-up study of 115 spinal cord injury patients treated with autologous bone marrow stem cells. Overall, nearly 6o% improved following treatment.
Muscle strength and endurance improved in over 50% of those treated and more than 4 in 10 patients reported a decrease in muscle spasticity. "We returned home and one week after the transplant I noticed my spasticity had decreased by about 85% and I could now put my feet flat on the floor… In March of 2009, I had my Baclofen pump removed," reported Mrs. Patricia Miller, who underwent her first treatment in December, 2008.
These results support the premise that spinal cord injury patients can be treated safely and effectively with autologous stem cell therapy.
The most common improvement, reported by more than 6 out of every 10 patients, was the return of feeling to the hands, feet, arms, legs or trunk.
Around 30% regained bowel and/or bladder function following treatment. A similar percentage experienced improvements in fine motor skills.
"These impressive results demonstrate the significant impact that stem cell therapy has for a majority of spinal injury patients who undergo treatment," remarked Dr. Hans de Munter, the XCell-Center's Chief Scientific Officer.
The treatment begins by collecting a small amount bone marrow from the patient's hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center's EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure, which consists of injecting the stem cells into the patient's spinal fluid using a spinal needle under local anesthesia.